BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35330330)

  • 1. Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care.
    Jones M; Akyea RK; Payne K; Humphries SE; Abdul-Hamid H; Weng S; Qureshi N
    J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.
    Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.
    Crosland P; Maconachie R; Buckner S; McGuire H; Humphries SE; Qureshi N
    Atherosclerosis; 2018 Aug; 275():80-87. PubMed ID: 29879685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating a clinical tool (FAMCAT) for identifying familial hypercholesterolaemia in primary care: a retrospective cohort study.
    Akyea RK; Qureshi N; Kai J; de Lusignan S; Sherlock J; McGee C; Weng S
    BJGP Open; 2020 Dec; 4(5):. PubMed ID: 33144363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electronic health record-based facilitation of familial hypercholesterolaemia detection sensitivity of different algorithms in genetically confirmed patients.
    Mohammadnia N; Akyea RK; Qureshi N; Bax WA; Cornel JH
    Eur Heart J Digit Health; 2022 Dec; 3(4):578-586. PubMed ID: 36710904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study.
    Ramli AS; Qureshi N; Abdul-Hamid H; Kamal A; Kanchau JD; Shahuri NS; Akyea RK; Silva L; Condon L; Abdul-Razak S; Al-Khateeb A; Chua YA; Mohamed-Yassin MS; Baharudin N; Badlishah-Sham SF; Abdul Aziz AF; Mohd Kasim NA; Sheikh Abdul Kadir SH; Kai J; Leonardi-Bee J; Nawawi H
    JMIR Res Protoc; 2023 Jun; 12():e47911. PubMed ID: 37137823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care.
    Weng S; Kai J; Akyea R; Qureshi N
    Lancet Public Health; 2019 May; 4(5):e256-e264. PubMed ID: 31054643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
    Ahmad ZS; Andersen RL; Andersen LH; O'Brien EC; Kindt I; Shrader P; Vasandani C; Newman CB; deGoma EM; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Kullo IJ; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    J Clin Lipidol; 2016; 10(5):1223-9. PubMed ID: 27678440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study.
    Molnar S; Scharnagl H; Delgado GE; Krämer BK; Laufs U; März W; Kleber ME; Katzmann JL
    Eur Heart J Qual Care Clin Outcomes; 2024 Jan; ():. PubMed ID: 38196142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels.
    Martinsen MH; Hedegaard BS; Klausen IC; Mortensen MB
    Dan Med J; 2019 Nov; 66(11):. PubMed ID: 31686647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Identification of Familial Hypercholesterolaemia in Primary Care-A Systematic Review.
    Silva L; Qureshi N; Abdul-Hamid H; Weng S; Kai J; Leonardi-Bee J
    J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33920869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia.
    Brown EE; Byrne KH; Davis DM; McClellan R; Leucker T; Jones SR; Martin SS
    J Clin Lipidol; 2020; 14(3):331-338. PubMed ID: 32220565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying an LDL-C threshold-based approach to identify individuals with familial hypercholesterolemia.
    Jasani R; Ahmad Z; Schneider R; Tujardon C; Basit M; Khera A
    J Clin Lipidol; 2022; 16(4):508-515. PubMed ID: 35568683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
    Miserez AR; Martin FJ; Spirk D
    Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.